全文获取类型
收费全文 | 3262篇 |
免费 | 144篇 |
国内免费 | 41篇 |
专业分类
耳鼻咽喉 | 31篇 |
儿科学 | 36篇 |
妇产科学 | 113篇 |
基础医学 | 292篇 |
口腔科学 | 106篇 |
临床医学 | 253篇 |
内科学 | 779篇 |
皮肤病学 | 39篇 |
神经病学 | 261篇 |
特种医学 | 121篇 |
外科学 | 728篇 |
综合类 | 18篇 |
预防医学 | 136篇 |
眼科学 | 152篇 |
药学 | 159篇 |
中国医学 | 2篇 |
肿瘤学 | 221篇 |
出版年
2023年 | 32篇 |
2022年 | 78篇 |
2021年 | 113篇 |
2020年 | 62篇 |
2019年 | 88篇 |
2018年 | 132篇 |
2017年 | 99篇 |
2016年 | 95篇 |
2015年 | 119篇 |
2014年 | 142篇 |
2013年 | 185篇 |
2012年 | 262篇 |
2011年 | 280篇 |
2010年 | 143篇 |
2009年 | 149篇 |
2008年 | 273篇 |
2007年 | 274篇 |
2006年 | 218篇 |
2005年 | 194篇 |
2004年 | 170篇 |
2003年 | 116篇 |
2002年 | 111篇 |
2001年 | 14篇 |
2000年 | 5篇 |
1999年 | 9篇 |
1998年 | 23篇 |
1997年 | 8篇 |
1996年 | 10篇 |
1995年 | 7篇 |
1994年 | 5篇 |
1993年 | 1篇 |
1991年 | 2篇 |
1990年 | 1篇 |
1988年 | 2篇 |
1987年 | 2篇 |
1983年 | 1篇 |
1982年 | 4篇 |
1981年 | 2篇 |
1980年 | 1篇 |
1978年 | 3篇 |
1977年 | 2篇 |
1976年 | 2篇 |
1965年 | 1篇 |
1964年 | 3篇 |
1963年 | 2篇 |
1960年 | 1篇 |
1959年 | 1篇 |
排序方式: 共有3447条查询结果,搜索用时 15 毫秒
41.
Mimidis K Papadopoulos V Katsinelos P Deftereos S Filippou D Kartalis G 《Romanian journal of gastroenterology》2004,13(1):39-41
Gastrocolic fistula is rarely described in the literature. It has been associated with a variety of diseases and recently with benign gastric ulcers related to the use of nonsteroidal anti-inflammatory drugs (NSAIDs'). The present case represents the first report of gastrocolic fistula due to NSAIDs in a cirrhotic patient. This is in keeping with the established knowledge that cirrhotic patients constitute a high-risk group of patients when treated with NSAIDs'. Review of the literature shows that this condition warrants a complete diagnostic work-up to exclude more ominous underlined diseases. 相似文献
42.
Federica Cipriani Mohammad Alzoubi David Fuks Francesca Ratti Takayuki Kawai Giammauro Berardi Leonid Barkhatov Panagiotis Lainas Marcel Van der Poel Morad Faoury Marc G. Besselink Mathieu DHondt Ibrahim Dagher Bjorn Edwin Roberto Ivan Troisi Olivier Scatton Brice Gayet Luca Aldrighetti Mohammad Abu Hilal 《Journal of hepato-biliary-pancreatic sciences》2020,27(1):3-15
43.
44.
45.
46.
Vasilios G. Athyros Niki Katsiki Konstantinos Tziomalos Thomas D. Gossios Eleni Theocharidou Eygenia Gkaliagkousi Panagiotis Anagnostis Efstathios D. Pagourelias Asterios Karagiannis Dimitri P. Mikhailidis for the GREACE Study Collaborative Group 《Archives of Medical Science》2013,9(3):418-426
Introduction
The effect of cardiovascular disease (CVD) prevention measures aimed at elderly patients requires further evidence. We investigated the effect of statin treatment (targeted to achieve guideline goals) on CVD outcomes in different age groups to determine whether statins are more beneficial in the elderly.Material and methods
The primary endpoint of this post hoc analysis of the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study (n = 1,600 patients with established coronary heart disease (CHD), mean follow-up 3 years) was the absolute and relative CVD event (a composite of death, myocardial infarction, revascularization, unstable angina, heart failure and stroke) risk reduction in age quartiles (each n = 200). Patients on “structured care” with atorvastatin (n = 800) followed up by the university clinic and treated to lipid goal were compared with the corresponding quartiles on “usual care” (n = 800) followed up by specialists or general practitioners of the patient''s choice outside the hospital.Results
In the elderly (mean age 69 ±4 and 70 ±3 years in the “structured” and “usual care”, respectively) the absolute CVD event reduction between “structured” and “usual care” was 16.5% (p < 0.0001), while in the younger patients (mean age 51 ±3 years and 52 ±3 years in the “structured” and “usual care”, respectively) this was 8.5% (p = 0.016); relative risk reduction (RRR) 60% (p < 0.0001) vs. 42% respectively (p = 0.001). The elderly had higher rates of chronic kidney disease and higher uric acid levels, plus an increased prevalence of diabetes, metabolic syndrome and non-alcoholic fatty liver disease. These factors might contribute to the increased CVD risk in older patients.Conclusions
All age groups benefited from statin treatment, but the elderly on “structured care” had a greater absolute and relative CVD risk reduction than the younger patients when compared with the corresponding patients assigned to “usual care”. These findings suggest that we should not deprive older patients of CVD prevention treatment and lipid target achievement. 相似文献47.
Dimopoulos MA Kastritis E Delimpasi S Katodritou E Hatzimichael E Kyrtsonis MC Repousis P Tsirogianni M Kartasis Z Parcharidou A Michael M Michalis E Tsatalas C Stefanoudaki E Hatjiharissi E Gika D Symeonidis A Terpos E Zervas K;Greek Myeloma Study Group 《European journal of haematology》2012,89(1):10-15
48.
49.
50.
Aghayeva Fidan A. Chronopoulos Panagiotis Schuster Alexander K. Pfeiffer Norbert Hoffmann Esther M. 《Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie》2021,259(10):3045-3053
Graefe's Archive for Clinical and Experimental Ophthalmology - This study assesses short-term intraocular pressure (IOP) change in the fellow eye of glaucoma patients after mitomycin... 相似文献